FDCDDQ
ONCY

Federation des caisses Desjardins du Quebec’s Oncolytics Biotech ONCY Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34.7K Buy
36,501
+2
+0% +$2 ﹤0.01% 2025
2026
Q1 		$31K Buy
36,499
+4,600
+14% +$4.58K ﹤0.01% 1989
2025
Q4 		$27.9K Hold
31,899
– – ﹤0.01% 1971
2025
Q3 		$44.7K Sell
31,899
-3,895
-11% -$4.36K ﹤0.01% 1837
2025
Q2 		$26.8K Buy
35,794
+20,000
+127% +$10.6K ﹤0.01% 1727
2025
Q1 		$8.67K Sell
15,794
-2
-0% -$1 ﹤0.01% 2007
2024
Q4 		$14.4K Hold
15,796
– – ﹤0.01% 1764
2024
Q3 		$13.9K Buy
15,796
+2,502
+19% +$2.46K ﹤0.01% 1777
2024
Q2 		$13.1K Buy
13,294
+10,000
+304% +$10.9K ﹤0.01% 1733
2024
Q1 		$4.68K Hold
3,294
– – ﹤0.01% 1976
2023
Q4 		$4.36K Sell
3,294
-736
-18% -$1.15K ﹤0.01% 1933
2023
Q3 		$8.66K Buy
4,030
+1,491
+59% +$3.64K ﹤0.01% 1805
2023
Q2 		$6.52K Sell
2,539
-2,105
-45% -$3.5K ﹤0.01% 1853
2023
Q1 		$5.56K Sell
4,644
-1,263
-21% -$1.98K ﹤0.01% 1884
2022
Q4 		$9.56K Sell
5,907
-2,000
-25% -$3.04K ﹤0.01% 1886
2022
Q3 		$9.81K Buy
7,907
+4,000
+102% +$4.9K ﹤0.01% 1922
2022
Q2 		$3.76K Buy
3,907
+500
+15% +$608 ﹤0.01% 2196
2022
Q1 		$5.38K Hold
3,407
– – ﹤0.01% 2180
2021
Q4 		$4.71K Hold
3,407
– – ﹤0.01% 2215
2021
Q3 		$6.95K Hold
3,407
– – ﹤0.01% 2154
2021
Q2 		$9.34K Sell
3,407
-5,263
-61% -$16.1K ﹤0.01% 2070
2021
Q1 		$32.5K Sell
8,670
-7,715
-47% -$23K ﹤0.01% 1672
2020
Q4 		$38.5K Sell
16,385
-4,000
-20% -$9.58K ﹤0.01% 1569
2020
Q3 		$34.6K Buy
20,385
+3,300
+19% +$6.05K ﹤0.01% 1341
2020
Q2 		$32.2K Buy
17,085
+9,000
+111% +$16.9K ﹤0.01% 1325
2020
Q1 		$11.2K Sell
8,085
-7,600
-48% -$19K ﹤0.01% 1644
2019
Q4 		$74.3K Buy
15,685
+7,700
+96% +$8.69K ﹤0.01% 1399
2019
Q3 		$4.58K Hold
7,985
– – ﹤0.01% 1975
2019
Q2 		$13.8K Hold
7,985
– – ﹤0.01% 1771
2019
Q1 		$14.6K Hold
7,985
– – ﹤0.01% 1581
2018
Q4 		$14.3K Hold
7,985
– – ﹤0.01% 1552
2018
Q3 		$30.6K Hold
7,985
– – ﹤0.01% 1458
2018
Q2 		$42.8K Buy
+7,985
New +$49.2K ﹤0.01% 1388

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
SI
Seeds Investor New York $973M AUM 33.7% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ONCY Position: Q2 2026 in Review

Federation des caisses Desjardins du Quebec increased its Oncolytics Biotech (ONCY) stake by 0.01% in Q2 2026, buying an estimated $2 and bringing the position to 36,501 shares worth $34.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

Federation des caisses Desjardins du Quebec first reported a position in ONCY in Q2 2018 and has held it in 33 quarters since. The position peaked at $74.3K in Q4 2019. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.

  • Federation des caisses Desjardins du Quebec held 36,501 shares of Oncolytics Biotech worth $34.7K as of Q2 2026.
  • Federation des caisses Desjardins du Quebec bought 2 Oncolytics Biotech shares in Q2 2026, an estimated $2.
  • Oncolytics Biotech made up ﹤0.01% of Federation des caisses Desjardins du Quebec's portfolio in Q2 2026, its #2025 holding.
  • Federation des caisses Desjardins du Quebec first reported a position in Oncolytics Biotech in Q2 2018 and has held it in 33 quarters since.
  • Federation des caisses Desjardins du Quebec's Oncolytics Biotech position peaked at $74.3K in Q4 2019.
  • 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q2 2026, filed 14 Aug 2026.